Abu Dhabi Investment Authority in Foghorn Therapeutics Inc.
Completed. First disclosed October 22, 2020, in a Form 3 (source).
- Investor
- Abu Dhabi Investment Authority (United Arab Emirates)
- Target
- Foghorn Therapeutics Inc. (EDGAR CIK 1822462)
- Target country
- United States
- Sector
- Health and Life Sciences (SIC 2834)
- First disclosed
- October 22, 2020, Form 3
- Amount
- Not stated
- Stake at first disclosure
- Not stated
Source Filings and Releases
| Date | Document | Stated stake | Link |
|---|---|---|---|
| October 22, 2020 | Form 3 | Not applicable | View |
| October 28, 2020 | Form 4 | Not applicable | View |
Cite: Middle East Forum, “Abu Dhabi Investment Authority in Foghorn Therapeutics Inc.,” Gulf Sovereign Holdings, accessed October 13, 2026, https://statemoney.meforum.org/deal/adia-foghorn-therapeutics-inc-1822462/.
Gulf money also reaches U.S. universities and lobbyists: the Influence Tracker holds Section 117 gift and contract disclosures and FARA registrations, and the Campus Watch Map places that funding on specific campuses.